Singapore markets closed

TriSalus Life Sciences, Inc. (TLSI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.85+0.15 (+1.55%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
21,984
18,511
12,398
8,401
Cost of revenue
2,914
2,605
2,258
1,193
Gross profit
19,070
15,906
10,140
7,208
Operating expenses
Research development
29,725
29,510
21,358
14,224
Selling general and administrative
45,059
40,546
25,221
17,016
Total operating expenses
74,784
70,056
46,579
31,240
Operating income or loss
-55,714
-54,150
-36,439
-24,032
Interest expense
14
16
1
1,761
Total other income/expenses net
-8,732
-5,294
-10,918
-3,049
Income before tax
-63,972
-59,029
-47,178
-28,842
Income tax expense
17
9
9
3
Income from continuing operations
-63,989
-59,038
-47,187
-28,845
Net income
-63,989
-59,038
-47,187
-28,845
Net income available to common shareholders
-68,070
-63,277
-50,016
-28,845
Basic EPS
-1.99
-6.73
-161.55
-93.17
Diluted EPS
-1.99
-6.73
-161.55
-93.17
Basic average shares
26,317
9,396
309.609
309.609
Diluted average shares
26,317
9,396
309.609
309.609